RxDoctor Payments Data

Carlos Sarriera-Lazaro, MD

Dermatopathology · San Juan, PRNPI 1609278670

Payments from drug & device makers

$1,103in general payments, 2019–2025

Across 18 payments — averaging $61.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$375
  • Johnson & Johnson$303
  • Revance Therapeutics, Inc.$212
  • Lilly USA, LLC$118
  • Novartis$55
  • PBG Puerto Rico LLC$25
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$1,00391%
  • Education$1009%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie3$375
Johnson & Johnson(2 entities)6$303
Revance Therapeutics, Inc.3$212
Lilly USA, LLC1$118
Novartis3$55
PBG Puerto Rico LLC1$25
Sanofi1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few dermatopathology providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$32,217
Medicare patients
239
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate23$1,662
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc21$1,487
Ciclopirox20$815
Ketoconazole31$700
Triamcinolone Acetonide29$407
Mupirocin11$118

Paid to pharmacies, not to this prescriber.

Other dermatopathology in San Juan

Where these figures come from

Is this you, or does something look wrong? →